Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Pure Vaccine Solutions
New Vaccine Targets for Influenza and Research Discovered by Pure Vaccine Solutions, LLC Published in PNAS
May 27th, 2009
Pure Vaccine Solutions, a division of biopharmaceutical company Pure Protein, announced the company’s Chief Scientist, Dr. William Hildebrand, University of Oklahoma Health Sciences Center, has discovered important new influenza vaccine candidates that are conserved among virus strains. These results were published January 2009 in Proceedings of the National Academy of Sciences (PNAS). Using its proprietary discovery technology, Dr. Hildebrand’s team identified a discrete set of peptide sequences consistently presented by Major Histocompatibility Complex (MHC) class I, HLA-B*0702, molecules on the surface of influenza infected cells. The source of these peptide epitopes...
Source: Vaccine Weekly (2009-05-27)
|
